Human molecule-modified insecticidal protein and coding gene, design method and application thereof
A molecular modification and insecticidal protein technology, applied in the field of genetic engineering and biological control, can solve problems such as unreported, and achieve the effect of less harm to human body
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0042] In the present invention, the preparation method of the human-derived molecularly modified insecticidal protein GGCC_scFv is preferably prepared by a recombinant expression method. The method for preparing human-derived molecularly modified insecticidal proteins by the recombinant expression method preferably includes the following steps:
[0043] (1) Carry out double digestion and ligation of the gene encoding the modified insecticidal protein GGCC_scFv encoding the human molecule and the vector respectively, to obtain the recombinant vector;
[0044] (2) The recombinant vector is introduced into the expression system, induced and cultured, and the recombinantly expressed human-derived molecularly modified insecticidal protein GGCC_scFv is obtained.
[0045] In the present invention, the expression system is preferably a prokaryotic cell expression system. The prokaryotic expression system is preferably Escherichia coli. The strain of Escherichia coli is preferably E...
Embodiment 1
[0068] A method for designing and preparing a human-derived molecularly modified insecticidal protein, the specific steps are as follows:
[0069] (1) Perform BLAST comparison analysis on the amino acid sequences of anti-Cry1Ab toxin idiotype single-chain antibody B12_scFv and Cry1A toxoids (Cry1Aa, Cry1Ab, Cry1Ac), and analyze the similar sequences of B12 and Cry1A toxoids, respectively H-CDR 1, L -CDR 1, L-CDR 2 and GS-linker. The amino acid sequences of anti-Cry1Ab toxin idiotype monoclonal antibody G1_scFv and Cry1B toxoid were compared by BLAST analysis, and the similar sequences of G1 and Cry1B toxoid were analyzed, which were H-CDR1', H-CDR3', and L-CDR 2', respectively.
[0070] (2) Design splicing according to the results, and replace the heavy chain region (VH) of the anti-Cry1Ab toxin idiotype single chain antibody B12_scFv sequence with the heavy chain region (VH) of G1_scFv to obtain the recombinant antibody GGCC_scFv; or use the anti-Cry1Ab toxin idiotype The li...
Embodiment 2
[0077] Anti-CrylAb toxin idiotype single chain antibody B12_scFv, G1_scFv, modified GGCC_scFv, CCGG_scFv and Cry1A toxoids (Cry1Aa, Cry1Ab, Cry1Ac) were compared with the amino acid sequences of Cry1B toxin by BLAST analysis:
[0078] Anti-CrylAb toxin idiosyncratic single-chain antibody B12 (hereinafter referred to as B12_phage, derived from the phage vector pIT2, is a phage-displayed single-chain antibody (scFv), that is, a scFv co-expressed on the GIII protein of the phage coat, such as figure 1 The amino acid sequence shown on the upper left side) has been disclosed by the Chinese patent No. ZL201410037000.9. B12_scFv is the antibody sequence in B12_phage, which is recombined into the prokaryotic expression vector pET-26b for soluble expression of scFv, such as figure 1 Shown above middle.
[0079] Anti-CrylAb toxin idiosyncratic single-chain antibody G1 (hereinafter referred to as G1_phage, derived from the phage vector pIT2, is a phage-displayed single-chain antibody (sc...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com